CA1320162C - Methode de stabilisation de l'expression de la proteine heterologue, et vecteurs servant a cette fin - Google Patents
Methode de stabilisation de l'expression de la proteine heterologue, et vecteurs servant a cette finInfo
- Publication number
- CA1320162C CA1320162C CA000607908A CA607908A CA1320162C CA 1320162 C CA1320162 C CA 1320162C CA 000607908 A CA000607908 A CA 000607908A CA 607908 A CA607908 A CA 607908A CA 1320162 C CA1320162 C CA 1320162C
- Authority
- CA
- Canada
- Prior art keywords
- cat
- protein
- gene
- expression
- gene sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
- C12N9/1033—Chloramphenicol O-acetyltransferase (2.3.1.28)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23122488A | 1988-08-11 | 1988-08-11 | |
US231,224 | 1988-08-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1320162C true CA1320162C (fr) | 1993-07-13 |
Family
ID=22868276
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000607908A Expired - Fee Related CA1320162C (fr) | 1988-08-11 | 1989-08-09 | Methode de stabilisation de l'expression de la proteine heterologue, et vecteurs servant a cette fin |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0428615A4 (fr) |
JP (1) | JPH04501204A (fr) |
AU (1) | AU4216689A (fr) |
CA (1) | CA1320162C (fr) |
IL (1) | IL91272A0 (fr) |
WO (1) | WO1990001540A1 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW327194B (en) * | 1992-05-01 | 1998-02-21 | American Cyanamid Co | Novel amyloid precursor proteins and methods of using same |
NL9201173A (nl) * | 1992-07-01 | 1994-02-01 | Leuven K U Res & Dev | Vector voor positieve selectie van recombinanten. |
DK144093D0 (fr) * | 1993-12-23 | 1993-12-23 | Novo Nordisk As | |
US6031075A (en) * | 1996-02-05 | 2000-02-29 | Children's Hospital Medical Center | Mature alveolar SP-B and a process for producing the same |
JP4741076B2 (ja) * | 1998-07-10 | 2011-08-03 | サイオス インコーポレイテッド | 8より上または5未満のpIを有するペプチドを産生するための方法 |
AT410444B (de) * | 2001-03-02 | 2003-04-25 | Oesterr Forsch Seibersdorf | Verfahren zur detektion von nukleinsäuremolekülen |
EP2261250B1 (fr) | 2001-12-21 | 2015-07-01 | Human Genome Sciences, Inc. | Protéines de fusion d'albumine et GCSF |
HUE027902T2 (en) | 2004-02-09 | 2016-11-28 | Human Genome Sciences Inc Corp Service Company | Albumin fusion proteins |
AU2009324637B2 (en) | 2008-12-10 | 2016-09-08 | Paka Pulmonary Pharmaceuticals, Inc. | Methods and compositions for delivery of medicaments to the lungs |
CN117343200B (zh) * | 2023-12-04 | 2024-01-30 | 北京质肽生物医药科技有限公司 | 一种包含淀粉样核心多肽的融合蛋白、制备方法及其应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8314362D0 (en) * | 1983-05-24 | 1983-06-29 | Celltech Ltd | Polypeptide and protein products |
US4933280A (en) * | 1984-12-11 | 1990-06-12 | California Biotechnology Inc. | Recombinant DNA sequence encoding Alveolar Surfactant Protein |
GR861037B (en) * | 1985-04-22 | 1986-07-16 | Genentech Inc | Novel human tissue plasminogen activator mutants |
DE3523701A1 (de) * | 1985-07-03 | 1987-01-08 | Bayer Ag | Verfahren zur herstellung von proteinen und polypeptiden |
GB8518753D0 (en) * | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Microbiological products |
EP0290516A4 (fr) * | 1986-10-24 | 1989-11-14 | Jeffrey A Whitsett | Proteines associees a des agents tensioactifs hydrophobes pulmonaires. |
ES2120401T3 (es) * | 1986-11-17 | 1998-11-01 | Scios Inc | Proteina recombinante amiloide relacionados con la enfermedad de alzheimer. |
EP0383837B1 (fr) * | 1987-11-04 | 1998-02-04 | Byk Gulden Lomberg Chemische Fabrik GmbH | Proteines a effet tensio-actif alveolaire |
-
1989
- 1989-08-09 WO PCT/US1989/003417 patent/WO1990001540A1/fr not_active Application Discontinuation
- 1989-08-09 EP EP19890910335 patent/EP0428615A4/en not_active Withdrawn
- 1989-08-09 JP JP1509538A patent/JPH04501204A/ja active Pending
- 1989-08-09 AU AU42166/89A patent/AU4216689A/en not_active Abandoned
- 1989-08-09 CA CA000607908A patent/CA1320162C/fr not_active Expired - Fee Related
- 1989-08-10 IL IL91272A patent/IL91272A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP0428615A1 (fr) | 1991-05-29 |
IL91272A0 (en) | 1990-03-19 |
WO1990001540A1 (fr) | 1990-02-22 |
AU4216689A (en) | 1990-03-05 |
JPH04501204A (ja) | 1992-03-05 |
EP0428615A4 (en) | 1991-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6500645B1 (en) | N-terminally extended proteins expressed in yeast | |
Kaster et al. | Analysis of a bacterial hygromycin B resistance gene by transcriptional and translational fusions and by DNA sequencing | |
JP3730255B2 (ja) | イーストにおいて発現されたn末端に伸長した蛋白質 | |
EP0542863B1 (fr) | Expression de polypeptides recombines avec purification amelioree | |
KR100227167B1 (ko) | 인체혈청알부민의 n-말단 단편을 함유하는 융합단백질 | |
US20070010439A1 (en) | Production of human parathyroid hormone from microorganisms | |
CA1320162C (fr) | Methode de stabilisation de l'expression de la proteine heterologue, et vecteurs servant a cette fin | |
JPH0759193B2 (ja) | 外来性蛋白質発現用クロ−ニングベクタ− | |
JP4624495B2 (ja) | ヒト・インスリンの生成 | |
JP2970811B2 (ja) | 原核生物細胞中にポリペプチドを調製するための発現システム | |
JP3305781B2 (ja) | 新規なるdna分子及び宿主 | |
EP0797671B1 (fr) | Procede de production de proteines extracellulaires dans des bacteries | |
US6962796B1 (en) | Production of human parathyroid hormone from microorganisms | |
EP0946735B1 (fr) | Proteines a extension d'extremite n-terminal exprimees dans la levure | |
HU216335B (hu) | Eljárás peptidek előállítására | |
PT87211B (pt) | Processo para a preparacao de polipeptideos por manipulacao genetica | |
EP0225860B1 (fr) | Méthode pour transmettre des produits de gènes à un milieu de croissance de bactéries gram-négatives | |
JP4180112B2 (ja) | 酵母細胞におけるn末端を伸長されたタンパクの発現のためのベクター | |
US5378613A (en) | Method for increased expression of low molecular weight recombinant polypeptides | |
JPH05500615A (ja) | ヒルジン及び新規のヒルジンの組換え製造方法 | |
KR900001014B1 (ko) | 소 성장 호르몬 유도체 발현 벡터의 제조방법 | |
Ishizaki et al. | Production of recombinant human glucagon in the form of a fusion protein in Escherichia coli; recovery of glucagon by sequence-specific digestion | |
JP2769541B2 (ja) | 平衡型構成誘導性転写系 | |
KR900001015B1 (ko) | 재조합체 dna 발현 벡터의 제조방법 | |
PT607080E (pt) | Nova sequencia pro que permite a secrecao de proteinas heterologas a partir de uma celula de levedura |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKLA | Lapsed |